These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1424509)

  • 1. The activity of metal compounds against aerobic and anaerobic bacteria.
    Chin N; Neu HC
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):549-52. PubMed ID: 1424509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial activity of the new antibiotic vermisporin.
    Chin NX; Neu HC
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):755-7. PubMed ID: 1425739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of bovine summer mastitis bacteria to antimicrobial agents.
    Jousimies-Somer H; Pyörälä S; Kanervo A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):157-60. PubMed ID: 8787898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].
    Yamaguchi T; Yoshida I; Itoh Y; Tachibana M; Takahashi C; Kaku M; Kanemitsu K; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Baba H; Matsuo S; Asari S; Toyokawa M; Matsuoka K; Kusano N; Nose M; Murase M; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
    Jpn J Antibiot; 2010 Dec; 63(6):431-56. PubMed ID: 21425596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E; Galiński J; Szponar M; Piechowicz L
    Med Dosw Mikrobiol; 1995; 47(1-2):5-9. PubMed ID: 8523970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
    Fernandes PB; Chu DT; Swanson RN; Ramer NR; Hanson CW; Bower RR; Stamm JM; Hardy DJ
    Antimicrob Agents Chemother; 1988 Jan; 32(1):27-32. PubMed ID: 3348609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
    Yoshida I; Yamaguchi T; Kudo R; Fuji R; Takahashi C; Oota R; Kaku M; Kunishima H; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Fujita S; Matsuo S; Kono H; Asari S; Toyokawa M; Kusano N; Nose M; Horii T; Tanimoto A; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
    Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1984 Mar; 25(3):319-26. PubMed ID: 6232895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative in vitro activity of ertapenem against aerobic and anaerobic bacteria].
    Loza E; Morosini MI; Cantón R; Almaraz F; Reig M; Baquero F
    Rev Esp Quimioter; 2003 Jun; 16(2):209-15. PubMed ID: 12973459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of LY146032 (daptomycin), a new peptolide.
    Ehlert F; Neu HC
    Eur J Clin Microbiol; 1987 Feb; 6(1):84-90. PubMed ID: 3032611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial properties of pexiganan, an analog of magainin.
    Ge Y; MacDonald DL; Holroyd KJ; Thornsberry C; Wexler H; Zasloff M
    Antimicrob Agents Chemother; 1999 Apr; 43(4):782-8. PubMed ID: 10103181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of MDL 62,879 (GE2270 A) against aerobic gram-positive and anaerobic bacteria.
    King A; Bethune L; Phillips I
    Antimicrob Agents Chemother; 1993 Apr; 37(4):746-9. PubMed ID: 8494370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of A-16686, a new glycopeptide.
    Neu HC; Neu NM
    Chemotherapy; 1986; 32(5):453-7. PubMed ID: 3757587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.
    Dubreuil L; Houcke I; Mouton Y; Rossignol JF
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2266-70. PubMed ID: 8891127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of MC-352, a new 16-membered macrolide.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1699-702. PubMed ID: 1416853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the new glycopeptide decaplanin.
    Neu HC; Chin NX; Niu WW
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Barlam T; Neu HC
    Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.